معرفی
Christopher Siedlecki serves as the Jane A. Fetter Professor in the Department of Surgery, Division of Applied Biomedical Engineering, at The Pennsylvania State University College of Medicine, with an additional professorship in Biomedical Engineering. His academic career is marked by extensive research in biomaterials, particularly focusing on blood-material interactions and surface engineering for medical devices.
Dr. Siedlecki's research interests center on the molecular and cellular interactions at biomaterial interfaces. Key areas include protein adsorption (especially fibrinogen), platelet adhesion and activation under shear flow, bacterial adhesion and biofilm formation, and the development of nanotextured polymer surfaces to mitigate these responses. His laboratory utilizes high-speed atomic force microscopy to observe real-time biomolecular dynamics, providing critical insights for designing hemocompatible and infection-resistant biomaterials.
Analysis of recent publications (2024-2025) reveals a strong emphasis on translational biomaterials research. His team investigates the role of coagulation factors in thrombosis using microfluidic models, explores the biophysical properties of viral RNA, and develops small-molecule-modified polyurethanes to combat biofilm formation. This work bridges fundamental surface science with clinical applications in cardiovascular devices and implants.
Dr. Siedlecki's recognition includes:
- Career Citation Milestone Award - D (500) Club (2020)
He has secured substantial research funding from NIH, NHLBI, and NSF. Notable projects include the development of high-speed atomic force microscopy for biomedical research, combinatorial approaches to blood-contacting biomaterials, and nanotextured polyurethanes for reduced platelet adhesion. These grants support interdisciplinary collaborations aimed at improving the safety and efficacy of medical devices.
His research group operates within the Division of Applied Biomedical Engineering, fostering collaborations across engineering, medicine, and basic science to tackle challenges in biomaterials and device-related complications.
